Please enable JavaScript in your browser. 
Skip to main content
Drug Information Portal National Library of Medicine
Home
 
       Home    Substance
     
Result
PropertyValue
Drug Name: Lerdelimumab [INN]
Description: Human anti-TGF beta 2 antibody for preventing post-operative scarring in patients undergoing surgery for glaucoma (trabulectomy); also has potential for the treatment of fibrosis, cataract, retinopathy and connective tissue disease. 


 
 
Site Map, Contact Us, Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act
Drug Information Portal Mobile Site
Last updated: Jun 2018
USA.gov